[go: up one dir, main page]

FR2985185B1 - Utilisation en therapeutique de derives d'imidazopyridine - Google Patents

Utilisation en therapeutique de derives d'imidazopyridine

Info

Publication number
FR2985185B1
FR2985185B1 FR1250075A FR1250075A FR2985185B1 FR 2985185 B1 FR2985185 B1 FR 2985185B1 FR 1250075 A FR1250075 A FR 1250075A FR 1250075 A FR1250075 A FR 1250075A FR 2985185 B1 FR2985185 B1 FR 2985185B1
Authority
FR
France
Prior art keywords
therapeutic use
imidazopyridine derivatives
imidazopyridine
derivatives
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1250075A
Other languages
English (en)
Other versions
FR2985185A1 (fr
Inventor
Chantal Alcouffe
Corentin Herbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47630451&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2985185(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR1250075A priority Critical patent/FR2985185B1/fr
Priority to PL13702101T priority patent/PL2800566T3/pl
Priority to KR1020147021454A priority patent/KR102046196B1/ko
Priority to CA2860413A priority patent/CA2860413C/fr
Priority to ES13702101.0T priority patent/ES2560619T3/es
Priority to SG11201403793UA priority patent/SG11201403793UA/en
Priority to PCT/IB2013/050048 priority patent/WO2013102860A1/fr
Priority to EA201491307A priority patent/EA027058B1/ru
Priority to JP2014550790A priority patent/JP6067032B2/ja
Priority to MX2014008244A priority patent/MX336340B/es
Priority to BR112014016632A priority patent/BR112014016632A8/pt
Priority to HK14112128.4A priority patent/HK1198690A1/xx
Priority to EP13702101.0A priority patent/EP2800566B1/fr
Priority to CN201380012217.8A priority patent/CN104144687B/zh
Priority to US14/370,462 priority patent/US9732078B2/en
Priority to AU2013207082A priority patent/AU2013207082B2/en
Priority to UY0001034564A priority patent/UY34564A/es
Priority to TW102100344A priority patent/TWI557122B/zh
Publication of FR2985185A1 publication Critical patent/FR2985185A1/fr
Application granted granted Critical
Publication of FR2985185B1 publication Critical patent/FR2985185B1/fr
Priority to IL233493A priority patent/IL233493A/en
Priority to CL2014001784A priority patent/CL2014001784A1/es
Priority to PH12014501537A priority patent/PH12014501537A1/en
Priority to ZA2014/04928A priority patent/ZA201404928B/en
Priority to MA37231A priority patent/MA35878B1/fr
Priority to CO14163266A priority patent/CO7020916A2/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FR1250075A 2012-01-04 2012-01-04 Utilisation en therapeutique de derives d'imidazopyridine Expired - Fee Related FR2985185B1 (fr)

Priority Applications (24)

Application Number Priority Date Filing Date Title
FR1250075A FR2985185B1 (fr) 2012-01-04 2012-01-04 Utilisation en therapeutique de derives d'imidazopyridine
EP13702101.0A EP2800566B1 (fr) 2012-01-04 2013-01-03 Utilisation thérapeutique de dérivés d'imidazopyridine
US14/370,462 US9732078B2 (en) 2012-01-04 2013-01-03 Therapeutic use of imidazopyridine derivatives
CA2860413A CA2860413C (fr) 2012-01-04 2013-01-03 Utilisation therapeutique de derives d'imidazopyridine
ES13702101.0T ES2560619T3 (es) 2012-01-04 2013-01-03 Uso terapéutico de derivados de imidazopiridina
SG11201403793UA SG11201403793UA (en) 2012-01-04 2013-01-03 Therapeutic use of imidazopyridine derivatives
PCT/IB2013/050048 WO2013102860A1 (fr) 2012-01-04 2013-01-03 Utilisation thérapeutique de dérivés d'imidazopyridine
EA201491307A EA027058B1 (ru) 2012-01-04 2013-01-03 Терапевтическое применение имидазопиридиновых производных соединений
JP2014550790A JP6067032B2 (ja) 2012-01-04 2013-01-03 イミダゾピリジン誘導体の治療的使用
MX2014008244A MX336340B (es) 2012-01-04 2013-01-03 Utilizacion en terapeutica de derivados de imidazopiridina.
BR112014016632A BR112014016632A8 (pt) 2012-01-04 2013-01-03 uso terapêutico de derivados de imidazopiridina
HK14112128.4A HK1198690A1 (en) 2012-01-04 2013-01-03 Therapeutic use of imidazopyridine derivatives
PL13702101T PL2800566T3 (pl) 2012-01-04 2013-01-03 Zastosowanie terapeutyczne pochodnych imidazopirydyny
CN201380012217.8A CN104144687B (zh) 2012-01-04 2013-01-03 咪唑并吡啶衍生物的治疗用途
KR1020147021454A KR102046196B1 (ko) 2012-01-04 2013-01-03 이미다조피리딘 유도체의 치료적 용도
AU2013207082A AU2013207082B2 (en) 2012-01-04 2013-01-03 Therapeutic use of imidazopyridine derivatives
TW102100344A TWI557122B (zh) 2012-01-04 2013-01-04 咪唑并吡啶衍生物之醫療用途
UY0001034564A UY34564A (es) 2012-01-04 2013-01-04 Utilización en terapéutica de derivados de imidazopiridina
IL233493A IL233493A (en) 2012-01-04 2014-07-02 Imidazopyridine derivatives for cancer treatment
CL2014001784A CL2014001784A1 (es) 2012-01-04 2014-07-03 Uso de compuestos derivados de imidazopiridina sustituidos para el tratamiento del cancer de vejiga.
PH12014501537A PH12014501537A1 (en) 2012-01-04 2014-07-03 Therapeutic use of imidazopyridine derivatives
ZA2014/04928A ZA201404928B (en) 2012-01-04 2014-07-04 Therapeutic use of imidazopyridine derivatives
MA37231A MA35878B1 (fr) 2012-01-04 2014-07-23 Utilisation thérapeutique de dérivés d'imidazopyridine
CO14163266A CO7020916A2 (es) 2012-01-04 2014-07-28 Utilizacion en terapeutica de derivados de imidazopiridina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1250075A FR2985185B1 (fr) 2012-01-04 2012-01-04 Utilisation en therapeutique de derives d'imidazopyridine

Publications (2)

Publication Number Publication Date
FR2985185A1 FR2985185A1 (fr) 2013-07-05
FR2985185B1 true FR2985185B1 (fr) 2013-12-27

Family

ID=47630451

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1250075A Expired - Fee Related FR2985185B1 (fr) 2012-01-04 2012-01-04 Utilisation en therapeutique de derives d'imidazopyridine

Country Status (24)

Country Link
US (1) US9732078B2 (fr)
EP (1) EP2800566B1 (fr)
JP (1) JP6067032B2 (fr)
KR (1) KR102046196B1 (fr)
CN (1) CN104144687B (fr)
AU (1) AU2013207082B2 (fr)
BR (1) BR112014016632A8 (fr)
CA (1) CA2860413C (fr)
CL (1) CL2014001784A1 (fr)
CO (1) CO7020916A2 (fr)
EA (1) EA027058B1 (fr)
ES (1) ES2560619T3 (fr)
FR (1) FR2985185B1 (fr)
HK (1) HK1198690A1 (fr)
IL (1) IL233493A (fr)
MA (1) MA35878B1 (fr)
MX (1) MX336340B (fr)
PH (1) PH12014501537A1 (fr)
PL (1) PL2800566T3 (fr)
SG (1) SG11201403793UA (fr)
TW (1) TWI557122B (fr)
UY (1) UY34564A (fr)
WO (1) WO2013102860A1 (fr)
ZA (1) ZA201404928B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201591962A1 (ru) * 2013-05-10 2016-06-30 Нимбус Аполло, Инк. Ингибиторы акк и их применение
WO2018175512A1 (fr) * 2017-03-22 2018-09-27 Suzhou Baijibugong Pharmaceutical Technology Co. Ltd. Inhibiteurs de tyrosine kinase de bruton
CN115490687B (zh) * 2022-09-19 2023-10-27 国家烟草质量监督检验中心 3-苯并呋喃基硫咪唑并吡啶衍生物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2859997B1 (fr) 2003-09-18 2006-02-03 Sanofi Synthelabo Nouveaux derives d'indolizine 1,2,3,6,7,8 substituee, inhibiteurs des fgfs, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2883286B1 (fr) * 2005-03-16 2008-10-03 Sanofi Aventis Sa NOUVEAUX DERIVES D'IMIDAZO[1,5-a]PYRIDINES, INHIBITEURS DE FGFs, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
FR2896247B1 (fr) * 2006-01-13 2008-02-29 Sanofi Aventis Sa Composes dimeres agonistes des recepteurs des fgfs (fgfrs), leur procede de preparation et leur application en therapeutique
EP1891955A1 (fr) 2006-07-24 2008-02-27 Sanofi-Aventis Utilisation de dérivés de indolizines, inhibiteurs de FGF, pour la préparation d'un médicament pour le traitement d'affections dégénératives des articulations
CN1887878A (zh) 2006-07-26 2007-01-03 浙江大学 三嗪氮氧化物及合成方法和用途
FR2962437B1 (fr) * 2010-07-06 2012-08-17 Sanofi Aventis Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique

Also Published As

Publication number Publication date
AU2013207082A1 (en) 2014-07-31
IL233493A (en) 2017-02-28
UY34564A (es) 2013-09-02
CN104144687A (zh) 2014-11-12
HK1198690A1 (en) 2015-05-29
MX2014008244A (es) 2014-11-25
CL2014001784A1 (es) 2014-10-17
IL233493A0 (en) 2014-08-31
ZA201404928B (en) 2015-10-28
JP6067032B2 (ja) 2017-01-25
BR112014016632A8 (pt) 2017-07-04
KR20140107667A (ko) 2014-09-04
KR102046196B1 (ko) 2019-11-18
PH12014501537A1 (en) 2014-10-08
CA2860413C (fr) 2020-02-25
CN104144687B (zh) 2017-09-05
WO2013102860A1 (fr) 2013-07-11
EA201491307A1 (ru) 2014-11-28
TWI557122B (zh) 2016-11-11
TW201333008A (zh) 2013-08-16
US9732078B2 (en) 2017-08-15
FR2985185A1 (fr) 2013-07-05
US20140343054A1 (en) 2014-11-20
BR112014016632A2 (pt) 2017-06-13
ES2560619T3 (es) 2016-02-22
SG11201403793UA (en) 2014-08-28
EP2800566B1 (fr) 2015-10-28
EP2800566A1 (fr) 2014-11-12
CA2860413A1 (fr) 2013-07-11
MA35878B1 (fr) 2014-12-01
JP2015505311A (ja) 2015-02-19
CO7020916A2 (es) 2014-08-11
EA027058B1 (ru) 2017-06-30
AU2013207082B2 (en) 2017-06-15
MX336340B (es) 2016-01-15
PL2800566T3 (pl) 2016-04-29

Similar Documents

Publication Publication Date Title
CO6870033A2 (es) Compuestos terapéuticos y métodos de uso relacionados
HUE046216T2 (hu) 1H-pirazolo [3,4-b]piridin-származékok és terápiás alkalmazásuk
IL241184A0 (en) Naphthyridine derivatives useful as alpha-v-beta-6 integrin antagonists
CL2015000640A1 (es) Variantes de hppd y métodos de uso
EP2895111A4 (fr) Prothèses d'inversion de valvule mitrale
HRP20181855T1 (hr) Lipidi za formulacije namijenjene unosu terapijskog sredstva
HUE053688T2 (hu) Biciklusos heterociklusos vegyületek és ezek terápiában történõ alkalmazása
BR112013018852A2 (pt) Derivados do tipo azaindazol ou diazaindazol como medicamento
FI20105569L (fi) Kehonsisäinen hoitolaite
ME02914B (fr) Nouveaux agents thérapeutiques
HRP20190318T1 (hr) Farmaceutski ili kozmetički pripravak za liječenje alopecije
CO7000778A2 (es) Derivados de pirazolopiridina, su procedimiento de preparación y su uso terapéutico
IL229963A0 (en) Substituted quinolines and their use as medicaments
AR092198A1 (es) Derivados de pirazolopirimidinas
EP2934378A4 (fr) Repères d'orientation de cathéter
EP2850093A4 (fr) Polypeptides d'il-13 thérapeutiques
EP2919777A4 (fr) Administration transmuqueuse de tocotriénol
HRP20191361T1 (hr) Pripravci ceramidaze terapeutske kiseline i postupci njihove izrade i uporabe
BR112014000773A2 (pt) composições de nicotinamida e uso terapêutico das mesmas
EP2903647A4 (fr) Anticorps humains anti-vegfr-2/kdr
HUE045947T2 (hu) Formuláció IBS kezelésére
DK2897681T3 (da) Medicinsk applikator
IL233875A (en) Composition and use thereof in the treatment of anal rhagades
IL232404A0 (en) n-(4-quinolinylmethyl)-sulfonamide derivatives and their use as anthelmintics
BR302012005250S1 (pt) "configuração aplicada em dispositivo médico"

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

ST Notification of lapse

Effective date: 20160930